APA (7th ed.) Citation

Hitomi Sugino, Yu Sawada, & Motonobu Nakamura. (2022). Macular‐type cutaneous adverse reaction due to atezolizumab and pembrolizumab. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Hitomi Sugino, Yu Sawada, and Motonobu Nakamura. Macular‐type Cutaneous Adverse Reaction Due to Atezolizumab and Pembrolizumab. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Hitomi Sugino, et al. Macular‐type Cutaneous Adverse Reaction Due to Atezolizumab and Pembrolizumab. Frontiers Media S.A., 2022.